Optimize outcomes for FESS and balloon sinuplasty
Protect surgical outcomes, reduce symptoms and improve patient QoL3,4 by adding NEUROMARK® to FESS and balloon sinuplasty procedures.

Many Patients with Chronic Rhinosinusitis(CRS) also suffer from Chronic Rhinitis (CR) 2
While FESS and balloon sinuplasty relieve obstruction, these procedures do not address the root cause of inflammation caused by overactive nerves.
NEUROMARK is an innovative, clinically proven procedure designed to safely target overactive posterior nasal nerves (PNN) using low-power energy, providing durable relief from persistent symptoms.

At least 40% of CRS patients still have uncontrolled symptoms 3-5 years after surgery 3
NEUROMARK has shown significant symptom improvement for the symptoms that uncontrolled endoscopic sinus surgery patients report, including rhinorrhea, congestion, and postnasal drip. 4
When to consider adding NEUROMARK
NEUROMARK may be appropriate in patients whose symptoms are not fully explained or resolved by standard sinus interventions.
Drainage or rhinorrhea are dominant complaints
Persistent congestion drives symptoms despite
appropriate sinus intervention
Symptoms feel out of proportion to CT findings
Revision surgery is planned and residual disease
doesn’t explain symptoms
Symptoms respond to ipratropium but recur when
treatment stops

Typical Patient Stories
NEUROMARK may be appropriate in patients whose symptoms are not fully explained or resolved by standard sinus interventions.
What People Are Saying
Complete implementation support
NEURENT provides end-to-end support, including reimbursement guidance, facility adoption, and onboarding and training—helping you successfully implement NEUROMARK with confidence.
Frequently Asked Questions
If you don't see what you are looking for here, reach out to your healthcare provider or find a provider.
The NEUROMARK System uses propriety ENTelligent technology™ to target the overactive posterior nasal nerves (PNN) that cause the symptoms of Chronic Rhinitis. NEUROMARK utilizes controlled low-energy radiofrequency (RF) to create precise micro-lesions at target sites.
The CLARITY clinical study shows statistically significant and clinically meaningful symptom improvements in patients who receive NEUROMARK, with an 80% responder rate for reflective Total Nasal Symptom Score (rTNSS) as defined by a 30% reduction from baseline at 12 months.
NEUROMARK is an option for both long-term and newly diagnosed allergic and nonallergic Chronic Rhinitis patients. In the PARAGON 6-month clinical study, both allergic and nonallergic subgroups experienced significant improvement in all study outcome measures (p<.001) with no significant differences between subgroups.¹²
Unlike medication, which requires compliance to a regular schedule¹⁰, or surgery, which can be invasive and has a long recovery period, NEUROMARK treats symptoms directly at the source in a gentle, minimally invasive procedure.
Patients with common symptoms of Chronic Rhinitis such as excessive sneezing, rhinorrhea, postnasal drip, or frequent congestion may be good candidates for treatment. By recognizing these symptoms right away, you can help treat the source with NEUROMARK.
MyMark™ reimbursement and support services are available to provide you with everything you need when it comes to reimbursement support, from prior authorization and appeals support to case updates and billing inquiries. Talk to your local Area Sales Manager to learn more about MyMark.
*Testimonial reflects user experience and opinion of an actual patient. Individual results may vary.
**Reflective Total Nasal Symptom Score.
†Mini Rhinoconjunctivitis Quality of Life Questionnaire.
References:
.Yen DM, Davis GE, Ow RA, O’Malley EM, Del Signore AG. Two-year clinical outcomes after multipoint impedance-controlled radiofrequency ablation of the posterior nasal nerve for treatment of chronic rhinitis. Ear, Nose & Throat Journal. Published online October 9, 2025. doi:10.1177/01455613251382759
Nuutinen M, Lyly A, Virkkula P, et al. The relative proportion of comorbidities among rhinitis and rhinosinusitis patients and their impact on visit burden. Clin Transl Allergy. 2022;12(7):e12181. Published 2022 Jul 21. doi:10.1002/clt2.12181
van der Veen J, Seys SF, Timmermans M, Levie P, Jorissen M, Fokkens WJ, Hellings PW. Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre. Allergy 2017; 72: 282–290
Smith TL, Schlosser RJ, Mace JC, et al. Long-term outcomes of endoscopic sinus surgery in the management of adult chronic rhinosinusitis. International Forum of Allergy & Rhinology. 2019;9(8):831-841. doi:10.1002/alr.22369. 5. Reh DD, Lay K, Davis G, et al. Long-term outcomes follow ing impedance-controlled radiofrequency ablation for the treatment of chronic rhinitis. Laryngoscope Investig Otolaryngol. 2024;9(3):e1286. Published 2024 Jun 4. doi:10.1002/lio2.1286.
The NEUROMARK® System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis.
Please see Instructions for Use (IFU) for a complete listing of warnings, precautions, and adverse events.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.








